Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 225 participants.

Also called NCT05236348

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 225 participants (planned count) (from the registry)
Sponsor
  • Aktiia SA Registry lists this organization as the lead sponsor
Registry
  • NCT NCT05236348
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05236348. Non-randomized; no masking; primary purpose diagnostic. Start 2022-01-11 (actual); primary completion 2025-03-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation
Condition
Hypertension
Condition
Blood Pressure
Condition
Heart Rate
Intervention (Device)
Aktiia.product-us
Lead sponsor
Aktiia SA (class: industry)

Record details

Record id
cardio:ct-nct05236348
Content hash
47297f2c9fbf926bfc48a505fe4dbb3c9367aa0e5284d28d16eb325ae7a8ba8e